Novo Nordisk to cut 11 per cent of jobs
Novo Nordisk, the Danish maker of Ozempic and Wegovy, plans to reduce its workforce by 11 percent. This move comes as the company faces growing competition, particularly from U.S. rival Eli Lilly.
18 hours ago
2 mins read
